615.96歐元12.84(2.04%)
2023/09/21更新
績效 / 1月0.85%
3月5.47%
1年8.31%
晨星評等 - 1.現金1.14%
- 2.股票11.06%
- 3.債券0.13%
- 4.其他87.67%
- 1.美國87.78%
- 2.加拿大5.12%
- 3.歐洲不包含歐元區2.87%
- 4.英國1.89%
- 5.新興亞洲1.19%
- 1.argenx SE ADR6.60%
- 2.Vertex Pharmaceuticals Inc5.00%
- 3.Biogen Inc4.96%
- 4.Biomarin Pharmaceutical Inc4.04%
- 5.Amgen Inc3.67%
- 6.Alnylam Pharmaceuticals Inc3.19%
- 7.Xenon Pharmaceuticals Inc3.08%
- 8.Seagen Inc Ordinary Shares3.07%
- 9.Intra-Cellular Therapies Inc2.98%
- 10.Vaxcyte Inc Ordinary Shares2.76%
- 1.現金1.14%
- 2.股票11.06%
- 3.債券0.13%
- 4.其他87.67%
- 1.美國87.78%
- 2.加拿大5.12%
- 3.歐洲不包含歐元區2.87%
- 4.英國1.89%
- 5.新興亞洲1.19%
- 1.argenx SE ADR6.60%
- 2.Vertex Pharmaceuticals Inc5.00%
- 3.Biogen Inc4.96%
- 4.Biomarin Pharmaceutical Inc4.04%
- 5.Amgen Inc3.67%
- 6.Alnylam Pharmaceuticals Inc3.19%
- 7.Xenon Pharmaceuticals Inc3.08%
- 8.Seagen Inc Ordinary Shares3.07%
- 9.Intra-Cellular Therapies Inc2.98%
- 10.Vaxcyte Inc Ordinary Shares2.76%